Submitted by Anonymous (not verified) on 2 March 2026 - 11:35
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Nemluvio, nemolizumab, Date of authorisation: 12/02/2025, Revision: 5, Status: Authorised